An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE) | Zendy

Erin Gaughan | Zendy; Tom Quinn | Zendy; Andrew C. Mills | Zendy; Annya Bruce | Zendy; Jean Antonelli | Zendy; Alison C. MacKin | Zendy; Vassilios Aslanis | Zendy; Feng Li | Zendy; Richard A. O’Connor | Zendy; Cecilia Boz | Zendy; Ross Mills | Zendy; Philip Emanuel | Zendy; Matthew Burgess | Zendy; Giulia Rinaldi | Zendy; Asta Valančiūtė | Zendy; Bethany Mills | Zendy; Emma Scholefield | Zendy; Gareth Hardisty | Zendy; Emily Gwyer Findlay | Zendy; Richard Parker | Zendy; John Norrie | Zendy; James W. Dear | Zendy; Ahsan Akram | Zendy; Oliver Koch | Zendy; Kate Templeton | Zendy; David H. Dockrell | Zendy; Timothy Walsh | Zendy; Stephen Partridge | Zendy; Duncan Humphries | Zendy; Jie WangJairaj | Zendy; Robert J. Slack | Zendy; Hans Schambye | Zendy; De Phung | Zendy; Lise Gravelle | Zendy; Bertil Lindmark | Zendy; Manu Shankar-Hari | Zendy; Nikhil Hirani | Zendy; Tariq Sethi | Zendy; Kevin Dhaliwal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE)

Author(s) -

Erin Gaughan,

Tom Quinn,

Andrew C. Mills,

Annya Bruce,

Jean Antonelli,

Alison C. MacKin,

Vassilios Aslanis,

Feng Li,

Richard A. O’Connor,

Cecilia Boz,

Ross Mills,

Philip Emanuel,

Matthew Burgess,

Giulia Rinaldi,

Asta Valančiūtė,

Bethany Mills,

Emma Scholefield,

Gareth Hardisty,

Emily Gwyer Findlay,

Richard Parker,

John Norrie,

James W. Dear,

Ahsan Akram,

Oliver Koch,

Kate Templeton,

David H. Dockrell,

Timothy Walsh,

Stephen Partridge,

Duncan Humphries,

Jie WangJairaj,

Robert J. Slack,

Hans Schambye,

De Phung,

Lise Gravelle,

Bertil Lindmark,

Manu Shankar-Hari,

Nikhil Hirani,

Tariq Sethi,

Kevin Dhaliwal

Publication year - 2023

Publication title -

american journal of respiratory and critical care medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.272

H-Index - 374

eISSN - 1535-4970

pISSN - 1073-449X

DOI - 10.1164/rccm.202203-0477oc

Subject(s) - medicine , adverse effect , pneumonitis , tolerability , clinical trial , randomized controlled trial , pneumonia , lung

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Empowering knowledge with every search

About

About Careers Publisher Partners Contact Us

Learn

FAQs Blog Terms of Use Privacy Policy

About

Learn

Discover

Explore